KEZAR LIFE SCIENCES INC's ticker is KZR and the CUSIP is 49372L100. A total of 79 filers reported holding KEZAR LIFE SCIENCES INC in Q3 2020. The put-call ratio across all filers is 0.04 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2021 | $85,000 | -77.6% | 15,564 | -75.6% | 0.00% | – |
| Q1 2021 | $380,000 | +6.1% | 63,700 | -7.2% | 0.00% | – |
| Q4 2020 | $358,000 | +5.6% | 68,649 | -1.9% | 0.00% | – |
| Q3 2020 | $339,000 | +14.1% | 69,949 | +22.2% | 0.00% | – |
| Q2 2020 | $297,000 | – | 57,249 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Prosight Management, LP | 3,200,000 | $10,016,000 | 4.75% |
| Qiming U.S. Ventures Management, LLC | 828,711 | $2,593,865 | 3.14% |
| SPHERA FUNDS MANAGEMENT LTD. | 1,888,228 | $5,910,154 | 0.99% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 6,887,591 | $21,558,160 | 0.91% |
| Avidity Partners Management LP | 6,519,400 | $20,405,722 | 0.68% |
| Ikarian Capital, LLC | 841,596 | $2,634,195 | 0.60% |
| Opaleye Management Inc. | 625,000 | $1,956,250 | 0.59% |
| CHI Advisors LLC | 689,451 | $2,157,982 | 0.57% |
| Orbimed Advisors | 5,463,000 | $17,099,190 | 0.34% |
| Palo Alto Investors LP | 656,200 | $2,053,906 | 0.17% |